State of New Jersey Common Pension Fund D - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 101 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,335,000
-28.0%
265,4590.0%0.02%
-30.4%
Q1 2019$6,018,000
-11.4%
265,4590.0%0.02%
-20.7%
Q4 2018$6,793,000
-21.7%
265,4590.0%0.03%
-9.4%
Q3 2018$8,673,000
+44.0%
265,4590.0%0.03%
+39.1%
Q2 2018$6,021,000
+10.1%
265,459
+17.7%
0.02%
+9.5%
Q1 2018$5,467,000
-13.1%
225,4590.0%0.02%
-12.5%
Q4 2017$6,288,000
+14.5%
225,459
+40.5%
0.02%
+9.1%
Q3 2017$5,494,000
-14.1%
160,4590.0%0.02%
-15.4%
Q2 2017$6,393,000
+8.2%
160,4590.0%0.03%
+4.0%
Q1 2017$5,908,000
+15.5%
160,4590.0%0.02%
+13.6%
Q4 2016$5,115,000
-12.0%
160,4590.0%0.02%
-12.0%
Q3 2016$5,815,000
+59.7%
160,4590.0%0.02%
+47.1%
Q2 2016$3,641,000
+20.7%
160,4590.0%0.02%
+21.4%
Q1 2016$3,017,000
-42.6%
160,459
-50.0%
0.01%
+27.3%
Q4 2015$5,260,000
+198.4%
320,918
+100.0%
0.01%
+57.1%
Q3 2015$1,763,000
+8.0%
160,459
+27.9%
0.01%
+16.7%
Q2 2015$1,633,000
-25.0%
125,4590.0%0.01%
-25.0%
Q1 2015$2,177,000
+16.3%
125,4590.0%0.01%
+14.3%
Q4 2014$1,872,000
-35.3%
125,4590.0%0.01%
-36.4%
Q3 2014$2,892,000
-27.7%
125,4590.0%0.01%
-31.2%
Q2 2014$4,000,000125,4590.02%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$78,677,17613.94%
Irenic Capital Management LP 1,700,937$19,084,5139.15%
Weiss Asset Management LP 7,457,060$83,668,2133.41%
Newtyn Management, LLC 1,450,000$16,269,0003.36%
Palliser Capital (UK) Ltd 97,100$1,089,4622.65%
Chescapmanager LLC 850,988$9,5482.24%
Park West Asset Management LLC 1,920,324$21,546,0352.11%
Baupost Group 11,419,226$128,1242.09%
Saturn V Capital Management LP 141,339$1,334,3421.11%
Oasis Management Co Ltd. 296,960$3,331,8910.66%
View complete list of THERAVANCE BIOPHARMA INC shareholders